Skip to content

RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China

RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China: A Prospective, Observational, Community-Based Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07075029
Acronym
RAISE
Enrollment
28800
Registered
2025-07-20
Start date
2025-09-01
Completion date
2027-12-31
Last updated
2025-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Infections (ARIs)

Keywords

RSV, Acute Respiratory Infections, Community

Brief summary

This is a multicenter, prospective, observational, community-based study designed to evaluate the incidence of respiratory syncytial virus (RSV) infection among community-dwelling elderly individuals in China, as well as their cohabiting older adults and children, over a 24-month period. During the study, home visits will be conducted to collect nasopharyngeal (NP) swabs from all community residents aged ≥50 years who report symptoms of acute respiratory infection (ARI). Pathogen detection will be performed using both point-of-care testing (POCT) and centralized laboratory analysis.

Detailed description

The study will cover about 10 communities representing diverse geographical locations, economic conditions, and population densities.

Interventions

DIAGNOSTIC_TESTNP swabs

Nasopharyngeal (NP) swabs will be collected from all participants for respiratory pathogen detection using point-of-care testing (POCT) and/or centralized laboratory analysis.

Sponsors

Shanghai Huashen Institute of Microbes and Infections
CollaboratorUNKNOWN
Huashan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* CRE-ARI group: 1. Male or female adults aged ≥50 years (calculated based on date of birth and date of visit). 2. Presence one of the following conditions of ARI case definition : * At least two respiratory symptoms/signs within 48 hours prior to self-reporting OR * At least one respiratory symptom/sign + one systemic symptom/sign within 48 hours prior to self-reporting 3. Provision of written informed consent by the participant or their legal guardian, in accordance with local EC (Ethics Committee) requirements. * CAI group: 1. In the household, include at least one patient meeting the inclusion criteria (index case\[s\]) of CRE-ARI group. 2. Male or female adults aged ≥50 years or children aged\<5 years (calculated based on date of birth and date of visit). 3. In the household, apart from the index case(s), there are two or more members who meet the criteria (2) AND are willing to participate, regardless of whether these household members exhibit ARI symptoms. 4. Provision of written informed consent by the participant or their legal guardian, in accordance with local EC (Ethics Committee) requirements.

Exclusion criteria

1. Enrollment in the CRE-ARI group within the preceding 14 days. 2. Enrollment in the CRE-ARI group has been more than 4 times during the previous 12 months (applicable only to the CRE-ARI group enrollment). 3. For CAI group, if a household has been enrolled into CAI group within the previous 12 months. 4. Residence outside the designated study catchment area. 5. Unwilling to provide consent/assent (if applicable) to participate. 6. Unwilling to provide biological samples. 7. Any other situation deemed inappropriate for participation by the investigator, including potential risks to the subject upon enrollment or factors that may affect the interpretation of study results, such as clinical judgment, safety concerns, or the integrity of the study.

Design outcomes

Primary

MeasureTime frameDescription
Incidence rate of RSVFrom September 2025 to September 2027To investigate the incidence rate of RSV related acute respiratory infection (ARI) in community-dwelling adults of 50 years or older in China.

Secondary

MeasureTime frameDescription
Positive rate of RSVFrom September 2025 to September 2027.To investigate the positive rate of RSV in the community-dwelling adults of 50 years or older with ARI in China.
PrevalenceFrom September 2025 to September 2027.To investigate the prevalence of common upper respiratory system infection pathogens in community-dwelling adults aged 50 years or older with ARI in China.
Association between symptoms and pathogensFrom enrollment to the final sample collection on Day 7.To investigate the association between symptoms and pathogens in community-dwelling adults aged 50 years or older with ARIs through questionnaires. Symptoms include respiratory signs and symptoms, such as those related to upper and lower respiratory tract disease (URTD and LRTD), as well as systemic signs and symptoms.

Other

MeasureTime frameDescription
Assessment of risk and protective factors for RSV infection through questionnairesFrom September 2025 to September 2027.To explore risk and protective factors for RSV infection in community-dwelling adults aged 50 years or older with ARI. Information on potential risk and protective factors, such as smoking status, household size, and out-of-home activity patterns, will be collected through questionnaires.
Transmission of RSVFrom enrollment to the final sample collection on Day 7.To explore RSV transmission among high-risk household members (aged ≥50 years or \<5 years) living with community-dwelling ARI adults aged 50 years or older, through analysis of full-length RSV genomes from RSV-positive specimens. Sequencing data will be mapped, and candidate single nucleotide polymorphisms (SNPs) will be identified for further analysis.
Association between symptoms and pathogens in high risk household membersFrom enrollment to the final sample collection on Day 7.To explore the association between symptoms and pathogens in high risk household members (age ≥50 years or \<5 years) living together with community-dwelling ARI adults of 50 years or older through questionnaires. Symptoms include respiratory signs and symptoms, such as those related to upper and lower respiratory tract disease (URTD and LRTD), as well as systemic signs and symptoms.
PrevalenceFrom September 2025 to September 2027.To explore the prevalence of common upper respiratory system infection pathogen in high risk household members (age ≥50 years or \<5 years) living with community-dwelling ARI adults of 50 years or older.
Healthcare seeking behaviors through questionnairesFrom enrollment to the final sample collection on Day 7.To explore healthcare-seeking behaviors among community-dwelling adults aged 50 years or older with ARI through questionnaires. Healthcare-seeking behaviors include whether medical care was sought, adherence to medical advice versus self-medication, and the types of medications used.

Countries

China

Contacts

Primary ContactJingwen Ai, M.D.
jingwenai@fudan.edu.cn+86 13764990804

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026